LicianPro

GT Biopharma, Inc. ·

GTBP 8-K 2026-09-25

GT Biopharma, Inc. (GTBP) 8-K dated 2026-09-25 — accession 0001493152-26-044309.

GT Biopharma, Inc. (GTBP) is a biotechnology company listed on NASDAQ.

GT Biopharma, Inc. filed a 8-K on 2026-09-25. Accession 0001493152-26-044309.

This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported GTBP revenue for 2020-12-31 was $0. Net income was -$28.3M. GTBP currently screens at market cap $17.4M.

Not investment advice. The GTBP SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr